liu.seSearch for publications in DiVA
Change search
ReferencesLink to record
Permanent link

Direct link
Pathogenic implications for autoantibodies against C-reactive protein and other acute phase proteins
Linköping University, Faculty of Health Sciences. Linköping University, Department of Molecular and Clinical Medicine, Rheumatology. Östergötlands Läns Landsting, Centre for Medicine, Department of Rheumatology in Östergötland.
Linköping University, Faculty of Health Sciences. Linköping University, Department of Molecular and Clinical Medicine, Rheumatology.ORCID iD: 0000-0002-6916-5490
2007 (English)In: Clinica Chimica Acta, ISSN 0009-8981, E-ISSN 1873-3492, Vol. 378, no 1-2, 13-23 p.Article in journal (Refereed) Published
Abstract [en]

Systemic lupus erythematosus (SLE) is a systemic rheumatic disease characterized clinically by multiorgan involvement and serologically by the occurrence of antinuclear antibodies. SLE patients may present with multiple autoantibodies to cytoplasmic and cell surface antigens as well as to circulating plasma proteins. Another feature of SLE is that serum levels of C-reactive protein (CRP) often remain low despite high disease activity and despite high levels of other acute phase proteins and interleukin-6, i.e. the main CRP inducing cytokine. Apart from its important role as a laboratory marker of inflammation, CRP attracts increasing interest due to its many intriguing biological functions, one of which is a role as an opsonin contributing to the elimination of apoptotic cell debris, e.g. nucleosomes, thereby preventing immunization against autoantigens. Recently, autoantibodies against CRP and other acute phase proteins have been reported in certain rheumatic conditions, including SLE. Although the presence of anti-CRP autoantibodies does not explain the failed CRP response in SLE, antibodies directed against acute phase proteins have several implications of pathogenetic interest. This paper thus highlights the biological and clinical aspects of native and monomeric CRP and anti-CRP, as well as autoantibodies against mannose-binding lectin, serum amyloid A and serum amyloid P component. © 2006 Elsevier B.V. All rights reserved.

Place, publisher, year, edition, pages
2007. Vol. 378, no 1-2, 13-23 p.
National Category
Medical and Health Sciences
URN: urn:nbn:se:liu:diva-37639DOI: 10.1016/j.cca.2006.12.002Local ID: 36971OAI: diva2:258488
Available from: 2009-10-10 Created: 2009-10-10 Last updated: 2015-06-29

Open Access in DiVA

fulltext(511 kB)128 downloads
File information
File name FULLTEXT01.pdfFile size 511 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Sjöwall, ChristofferWetterö, Jonas
By organisation
Faculty of Health SciencesRheumatologyDepartment of Rheumatology in Östergötland
In the same journal
Clinica Chimica Acta
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
Total: 128 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 80 hits
ReferencesLink to record
Permanent link

Direct link